Cite
HARVARD Citation
Lee, H. et al. (2020). Serum FAM19A5 in neuromyelitis optica spectrum disorders: Can it be a new biomarker representing clinical status?. Multiple sclerosis. pp. 1700-1707. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, H. et al. (2020). Serum FAM19A5 in neuromyelitis optica spectrum disorders: Can it be a new biomarker representing clinical status?. Multiple sclerosis. pp. 1700-1707. [Online].